Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cardiff LexingtonCDIX +0.79%27 Market Cap is $7.79 Mil as of Aug. 11, 2026. GuruFocus rates CDIX with a GF Score™ of 27/100 and a GF Value™ of $0.08 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 690 Healthcare Providers & Services companies, Cardiff Lexington ranks worse than 86.23% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cardiff Lexington's share price for the quarter that ended in Mar. 2026 was $2.584. Cardiff Lexington's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 15.17 Mil. Therefore, Cardiff Lexington's market cap for the quarter that ended in Mar. 2026 was $39.19 Mil.
Cardiff Lexington's quarterly market cap
increased
from Sep. 2025 ($29.86 Mil) to Dec. 2025 ($77.07 Mil) but then
declined
from Dec. 2025 ($77.07 Mil) to Mar. 2026 ($39.19 Mil).
Cardiff Lexington's annual market cap
increased
from Dec. 2023 ($0.36 Mil) to Dec. 2024 ($47.43 Mil) and
increased
from Dec. 2024 ($47.43 Mil) to Dec. 2025 ($77.07 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cardiff Lexington's Enterprise Value for Today is $39.24 Mil.
Cardiff Lexington (OTCPK:CDIX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cardiff Lexington Market Cap Related Terms
Cardiff Lexington Market Cap Historical Data
* Premium members only.
The historical data trend for Cardiff Lexington's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Cardiff Lexington's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cardiff Lexington Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cardiff Lexington's Market Cap distribution charts can be found below:
* The bar in red indicates where Cardiff Lexington's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cardiff Lexington's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cardiff Lexington (CDIX) has a Market Cap of $7.79 Mil as of Aug. 11, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cardiff Lexington and its competitors. According to the industry distribution chart, Cardiff Lexington ranks #595 out of 690 companies in the Healthcare Providers & Services industry, placing it in the top 86.2%.
Is Cardiff Lexington's Market Cap too high?
Cardiff Lexington's current Market Cap is $7.79 Mil. The Healthcare Providers & Services industry median Market Cap is 104.25. Cardiff Lexington's value of $7.79 Mil is 92.5% below this industry median. Based on the distribution chart, Cardiff Lexington ranks #595 out of 690 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cardiff Lexington has a GF Score™ of 27/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cardiff Lexington's Market Cap compare to AMS and SYRA?
According to the Healthcare Providers & Services industry distribution chart, Cardiff Lexington ranks #595 out of 690 companies for Market Cap. This places Cardiff Lexington in the lower half of its industry. The industry median Market Cap is 104.25. Cardiff Lexington's value of $7.79 Mil is 92.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 104.25, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cardiff Lexington's current Market Cap of $7.79 Mil is 92.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cardiff Lexington and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 104.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardiff Lexington's current Market Cap is $7.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardiff Lexington stock overvalued right now?
Based on GuruFocus' analysis, Cardiff Lexington (CDIX) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.08, compared to a current price of $0.51 — trading 537.5% above its estimated fair value. The current Market Cap is $7.79 Mil and 92.5% below the Healthcare Providers & Services industry median of 104.25. Cardiff Lexington's overall GF Score™ is 27/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cardiff Lexington (CDIX), the current Market Cap is $7.79 Mil as of Aug. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cardiff Lexington (CDIX) Overvalued in 2026?
Based on GuruFocus' analysis, Cardiff Lexington stock appears to be overvalued.
The current stock price of $0.51 is trading 537.5% above its estimated GF Value™ of $0.08.
GuruFocus considers Cardiff Lexington to be Significantly Overvalued.
Key valuation signals for CDIX:
Market Cap: $7.79 Mil
GF Value™: $0.08 vs. price of $0.51 (537.5% above fair value)
Industry Position: 92.5% below the Healthcare Providers & Services median (#595 of 690)
No single metric tells the full story. See the CDIX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cardiff Lexington Corp is an acquisition holding company, conducting its operations through its operating subsidiaries. The company has two reportable operating segments; Healthcare (Nova), and Real Estate (Edge View). The Healthcare segment generates all of the company's revenue and provides a full range of diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. The Real estate segment consists of Edge View, a real estate company that owns various acres zoned medium-density residential.
27GF Score
Get the complete analysis for CDIX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CDIX has been successfully added to your 
